Sino-American antibody company Adagene announced three separate updates on its activities at once on Thursday.

Merck & Co’s Keytruda (pembrolizumab)—in combination with paclitaxel, with or without bevacizumab—has been approved in the ...

Germany-based newly launched biotech venture builder, BSM Biotech Holdings, today announced that it has formally commenced ...

US biotech Nanoscope Therapeutics (Nasdaq: NSCI) has appointed Paul Hallen as chief operating officer, adding commercial and ...

Positive high-level results have been shared from the EMERALD-3 Phase III trial by AstraZeneca.

Nearly 8,000 clinical trial sites have been disrupted by the USA's escalating war on Iran, according to new analysis from ...

US biotechnology company PranaX has appointed Richard LeConey as chief medical officer, as it looks to strengthen clinical ...

US pharma major Eli Lilly (NYSE: LLY) has secured US regulator clearance for Foundayo (orforglipron), a once-daily oral GLP-1 ...

India-headquartered Lupin Limited revealed the completion of its acquisition of VISUfarma, a European specialty ...

Privately-held US cell therapy company Orca Bio announced that the US Food and Drug Administration (FDA) has extended the ...

The US Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center, announced that organizations ...

Precision oncology start-up Fore Biotherapeutics announced that the US Food and Drug Administration (FDA) has granted ...